BIO INX, a new spin-off from Ghent University and the VUB, is working on a bio-ink that can be used to 3D-print complex structures such as organs and human tissue based on stem cells.
Developed in the Belgian facilities of GSK's pharmaceutical laboratory, Arexvy is the world's first vaccine to combat Respiratory Syncytial Virus (RSV).
Classic blood pressure inhibitors may also help our immune system fight cancer cells better. This was discovered by scientists from UCLouvain's de Duve Institute, among others.